A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
about
Interferon for people with lamivudine-resistant chronic hepatitis B virus infectionAdefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infectionCombined DTP-HBV vaccine versus separately administered DTP and HBV vaccines for primary prevention of diphtheria, tetanus, pertussis, and hepatitis BLamivudine for chronic hepatitis B in adultsControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaHepatitis B Vaccination in Pregnancy in the United StatesPrevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in NepalHepatocellular carcinoma: a reviewSeroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countriesThe weight of obesity on the human immune response to vaccinationCurrent state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan regionHepatocellular Carcinoma Risk in Alaska Native Children and Young Adults with Hepatitis B Virus: Retrospective Cohort AnalysisNested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native peopleEpidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in EthiopiaIn the shadow of HIV/AIDS: forgotten diseases in sub-Saharan Africa: global health issues and funding agency responsibilities.Uncovering high rates of unsafe injection equipment reuse in rural Cameroon: validation of a survey instrument that probes for specific misconceptions.Anti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70.Using data to guide policy: next steps for preventing perinatal hepatitis B virus transmission in Cambodia.Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association.Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy.Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural NigeriaHepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study.Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failureA population-based study examining hepatitis B virus infection and immunization rates in Northwest ChinaSero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in UgandaHepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional studyEstimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental modelComputational modeling of interventions and protective thresholds to prevent disease transmission in deploying populationsAssociation of human leukocyte antigen DQB1 and DRB1 alleles with chronic hepatitis B.Hepatitis B virus: where do we stand and what is the next step for eradication?Hepatitis B vaccine by intradermal route in non responder patients: an update.The increasing burden of imported chronic hepatitis B--United States, 1974-2008.Alternative dosage schedules with HPV virus-like particle vaccines.Seroprevalence of hepatitis B and C viruses among medical waste handlers at Gondar town Health institutions, Northwest EthiopiaHepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohortsPrevalence of hepatitis B virus infection among blood donors at the Tamale Teaching Hospital, Ghana (2009).Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected GambiansThe effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5-15 y after primary immunization; China, 2009-2010.
P2860
Q24185973-911194DC-481D-4E18-BF48-CF8FF6EFAC85Q24187530-0560AFAB-5463-4B3F-A49F-921D87A19847Q24236040-DE38636F-3E6F-4B06-8B43-AF92B0228DB0Q24246121-B76E933A-00B0-48AA-8630-9B2FB4F097E6Q26772324-5B170CCD-3459-4C80-996D-4E26A76852CFQ27026187-61FF9D7A-C1DF-4462-9F8C-B130ACC860E9Q27303069-2124AEF5-BDD5-4388-9B6A-5ADE6E239EA8Q28069290-0DCC8AFA-ECEF-4C9C-BE26-F5394868D284Q28078813-03CBF11A-9005-40F6-9655-3C2154DE5DD6Q28088540-C8140567-B0E1-4764-93C2-5CE7F98F1500Q28541388-E4ACCBA3-9EB7-4161-96B6-AE232ACCADB8Q30151678-F8F394E7-7CE3-446F-95D6-369E952F4938Q30152115-5EE3FA2E-16BE-41B6-8F51-2A10125907C1Q30152150-D03BD1F3-405C-415A-8689-AD614F84E9C8Q30244568-0053FF52-B521-46E4-B24D-0A07735EFE16Q30382346-1090FCFB-4211-4D3A-AF51-2F85F478E7D2Q30420384-51E86530-5F5B-435E-8607-43F1F736BF2EQ30498212-95D26DB1-8AC4-4A97-9458-76E6A23A3E1BQ30531035-7AE716C8-50C3-451F-B27E-A27FC56A9DF0Q30576256-666106B0-4D04-4BA2-9BDB-44230938819BQ30634658-7973CF3E-5588-46AD-BA48-37E3303C1CFEQ30976535-D072795A-BD5C-4AE9-A537-E42CD086C472Q33349504-641BA2D9-4127-4D9C-ABCD-375AD93E6BEAQ33534469-FB223070-3579-45C7-B069-9B36A9F290E2Q33590502-9471B128-9D43-4EEA-98CA-84FB0C9BB003Q33618408-762F7A13-B910-42FB-AB56-509630F5E26AQ33619872-81D2E04D-A89F-4D7D-BDE6-E1D564E5ADD6Q33734612-481051EE-F9D0-42D8-A058-08A877EBC6A8Q33767254-2522C7AF-5B00-4857-A8E1-AFBD47D77385Q33804835-791F7D74-ABAB-4640-A896-99023127DFF7Q33845532-5C94B635-AECA-45A5-BAD3-285B98CEB713Q33958764-094C50DE-1211-491E-879D-2FD1D466B035Q34036643-2E7698D9-F9DD-4BBA-8196-957AB4978D09Q34098106-1786407F-9FC3-4046-96D0-F4D4500AFF29Q34102466-6CB9E7B9-78C6-4A01-9898-E76ED885BC19Q34134536-7867F4A0-30A6-4A0D-87D8-C05BB1E9636CQ34151438-3B8E35E9-EDEF-46ED-B5EE-6DA305D4D9EEQ34167101-90B3AED6-6522-4C49-B50B-AAC0CD661F6CQ34174489-32E8205A-A302-4D1C-8742-8150C2E31D9EQ34290738-B762463C-0026-46C0-8436-9A797594739D
P2860
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
A mathematical model to estima ...... burden and vaccination impact.
@en
A mathematical model to estima ...... burden and vaccination impact.
@nl
type
label
A mathematical model to estima ...... burden and vaccination impact.
@en
A mathematical model to estima ...... burden and vaccination impact.
@nl
prefLabel
A mathematical model to estima ...... burden and vaccination impact.
@en
A mathematical model to estima ...... burden and vaccination impact.
@nl
P2093
P2860
P356
P1476
A mathematical model to estima ...... burden and vaccination impact.
@en
P2093
Beth P Bell
Eric E Mast
Fangjun Zhou
Harold S Margolis
Stephen C Hadler
Susan T Goldstein
P2860
P304
P356
10.1093/IJE/DYI206
P577
2005-10-25T00:00:00Z